Corindus Vascular Robotics (CVRS) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/29/2026
- Visa (V) To Cut 7% Of Its Workforce, Totaling About 2,600 Jobs - Bloomberg
- HF Sinclair plans to spin off lubricants unit, close Canadian refinery
- SoFi Technologies (SOFI) Tops Q2 EPS by 1c ; Offers Guidance
- S&P 500 ends higher as investors await tech earnings
- NVIDIA’s rising CDS the talk of Wall Street amid circular financing fears
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
- After-Hours Stock Movers: GOOGL, TSLA, NOW, IBM, TXN, MOH, URI
- After-Hours Stock Movers: SMCI, OKLO, XE, PEGA, CLDX, ALK
Corindus Vascular Robotics (CVRS) PT Raised to $2 at Ladenburg Thalmann
March 13, 2019 9:18 AM EDTLadenburg Thalmann analyst Jeffrey Cohen raised the price target on Corindus Vascular Robotics (NYSE: CVRS) to $2.00 (from $1.70) while maintaining a Buy rating following the company's 4Q. Revenue, net loss, and loss per share for the quarter was $4.7 million, $7.4 million, and $0.04. Consensus estimate for the quarter were... More
